 |
|
Kyung-Ran Kim (Kim KR), Jong Min Kim (Kim JM), Ji-Man Kang (Kang JM), Yae-Jean Kim (Kim YJ)
Clin Exp Pediatr. 2016;59(6):252-255. Published online 2016 Jun 30 DOI: https://doi.org/10.3345/kjp.2016.59.6.252
|
|
Citations to this article as recorded by
 Immune Reconstitution Inflammatory Syndrome-Like Reaction During the Treatment of Pneumocystis jirovecii Pneumonia in an Infant With Severe Combined Immunodeficiency
Ching-Yu Lin, Sung-Min Lim, Soo-Yeon Kim, Seung-Min Hahn, Jong-Gyun Ahn, Ji-Man Kang
Pediatric Infection & Vaccine.2024;[Epub] CrossRef Prevention, Diagnosis and Management of Pneumocystis jirovecii Infection in Children With Cancer or Receiving Hematopoietic Cell Therapy
Shane J. Cross, Joshua Wolf, Pratik A. Patel
Pediatric Infectious Disease Journal.2023; 42(12): e479. CrossRef Economic Evaluation of Newborn Screening for Severe Combined Immunodeficiency
Sophy T. F. Shih, Elena Keller, Veronica Wiley, Melanie Wong, Michelle A. Farrar, Georgina M. Chambers
International Journal of Neonatal Screening.2022; 8(3): 44. CrossRef Modelling the Cost-Effectiveness and Budget Impact of a Newborn Screening Program for Spinal Muscular Atrophy and Severe Combined Immunodeficiency
Sophy T. F. Shih, Elena Keller, Veronica Wiley, Michelle A. Farrar, Melanie Wong, Georgina M. Chambers
International Journal of Neonatal Screening.2022; 8(3): 45. CrossRef Clinical Characteristics and Prognosis of the Modified Probable Pneumocystis jirovecii Pneumonia in Korean Children, 2001–2021
Kyoung Sung Yun, Bin Anh, Sung Hwan Choi, Kyung Taek Hong, Jung Yoon Choi, Ki Wook Yun, Hyoung Jin Kang, Eun Hwa Choi
Children.2022; 9(10): 1596. CrossRef Características clínico-epidemiológicas de la neumonía por Pneumocystis jirovecii en un hospital de tercer nivel en España
Laura Martín Pedraz, Begoña Carazo Gallego, David Moreno Pérez
Anales de Pediatría.2021; 95(1): 4. CrossRef Twice weekly prophylaxis with trimethoprim/sulfamethoxazole for Pneumocystis jirovecii pneumonia in pediatric oncology patients
Monica Awad, Caroline M Sierra, Elhaam Mesghali, Khaled Bahjri
Journal of Oncology Pharmacy Practice.2021; 27(8): 1936. CrossRef Clinical-epidemiological characteristics of Pneumocystis jirovecii pneumonia in a tertiary hospital in Spain
Laura Martín Pedraz, Begoña Carazo Gallego, David Moreno Pérez
Anales de Pediatría (English Edition).2021; 95(1): 4. CrossRef Pneumocystis jirovecii pneumonia in children. A retrospective study in a single center over three decades
Jorge García-Moreno, Susana Melendo-Pérez, María Teresa Martín-Gómez, Marie Antoinette Frick, Joan Balcells-Ramírez, Montserrat Pujol-Jover, Andrea Martín-Nalda, Natalia Mendoza-Palomar, Pere Soler-Palacín
Enfermedades Infecciosas y Microbiología Clínica.2020; 38(3): 111. CrossRef Pneumocystis jirovecii pneumonia in children. A retrospective study in a single center over three decades
Jorge García-Moreno, Susana Melendo-Pérez, María Teresa Martín-Gómez, Marie Antoinette Frick, Joan Balcells-Ramírez, Montserrat Pujol-Jover, Andrea Martín-Nalda, Natalia Mendoza-Palomar, Pere Soler-Palacín
Enfermedades infecciosas y microbiologia clinica (.2020; 38(3): 111. CrossRef Pneumocystis jiroveci pneumonia in Taiwan from 2014 to 2017: Clinical manifestations and outcomes between pediatric and adult patients
Hsin-Yao Lee, Chun-Yi Lu, Ping-Ing Lee, Jong-Min Chen, Li-Min Huang, Luan-Yin Chang
Journal of Microbiology, Immunology and Infection.2019; 52(6): 983. CrossRef Characteristic Features of Pneumocystis Pneumonia in Pediatric Acute Lymphoblastic Leukemia
Hyeon A Kim, Haemin Jang, Yu Kyung Kim, Dongsub Kim, Ji Yoon Kim
Clinical Pediatric Hematology-Oncology.2018; 25(2): 154. CrossRef
|